The CP conserving amplitudes for the decays K → 3π are calculated in Chiral Perturbation Theory at the next-to-leading order. We present the expressions in a compact form with single parameter functions only. These expressions are then fitted to all available K → 2π and K → 3π data to obtain a fit of the parameters that occur. We compare with the work of Kambor, Missimer and Wyler.
The scalar form factors for the pions and kaons are calculated in SU(3) Chiral Perturbation Theory at order p 6 , in the isospin limit m u = m d =m. We find in general sizable corrections of O(p 6 ). We use our results to obtain information on the 1/N c suppressed low energy constants L r 4 and L r 6 as well as on two O(p 6 ) low energy constants. We present some numerical results for masses and decay constants as well.We derive a relation for the scalar form factors analogous to Sirlin's relation for vector form factors.
We present the scattering lengths for the πK processes in the three flavour Chiral Perturbation Theory (ChPT) framework at next-to-next-to-leading order (NNLO). The calculation has been performed analytically but we only include analytical results for the dependence on the low-energy constants (LECs) at NNLO due to the size of the expressions. These results, together with resonance estimates of the NNLO LECs are used to obtain constraints on the Zweig rule suppressed LECs at NLO, L r 4 and L r 6 . Contrary to expectations from NLO order calculations we find them to be compatible with zero. We do a preliminary study of combining the results from ππ scattering, πK scattering and the scalar form-factors and find only a marginal compatibility with all experimental/dispersive input data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.